相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
Jeffrey Goldstein et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2017)
PET/CT with C-11-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data
Stefano Fanti et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
11C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel
Francesco Ceci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy
Nicola Fossati et al.
EUROPEAN UROLOGY (2016)
New Clinical Indications for 18F/11C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature
Laura Evangelista et al.
EUROPEAN UROLOGY (2016)
Serial 18F-choline-PET imaging in patients receiving enzalutamide for metastatic castration-resistant prostate cancer: response assessment and imaging biomarkers
Francesca Maines et al.
FUTURE ONCOLOGY (2016)
Imaging biomarkers in prostate cancer: role of PET/CT and MRI
M. Picchio et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
Francesco Ceci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Metastasis-directed Therapy of Regional and Distant Recurrences After Curative Treatment of Prostate Cancer: A Systematic Review of the Literature
Piet Ost et al.
EUROPEAN UROLOGY (2015)
Long-term Outcomes of Salvage Lymph Node Dissection for Clinically Recurrent Prostate Cancer: Results of a Single-institution Series with a Minimum Follow-up of 5 Years
Nazareno Suardi et al.
EUROPEAN UROLOGY (2015)
Prospective Comparison of F-18-Fluoromethylcholine Versus Ga-68-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy
Joshua J. Morigi et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Natural history of surgically treated high-risk prostate cancer
Alberto Briganti et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy
B. Meller et al.
EJNMMI RESEARCH (2015)
PROSTATE CANCER Identifying sites of recurrence with choline-PET-CT imaging
Paolo Castellucci et al.
NATURE REVIEWS UROLOGY (2015)
Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abiraterone
Ugo De Giorgi et al.
Oncotarget (2015)
Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial
Francesco Ceci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
Axel Heidenreich et al.
EUROPEAN UROLOGY (2014)
Prediction of Outcome Following Early Salvage Radiotherapy Among Patients with Biochemical Recurrence After Radical Prostatectomy
Alberto Briganti et al.
EUROPEAN UROLOGY (2014)
Early Biochemical Relapse After Radical Prostatectomy: Which Prostate Cancer Patients May Benefit from a Restaging 11C-Choline PET/CT Scan Before Salvage Radiation Therapy?
Paolo Castellucci et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
The Role of 11C-Choline PET Imaging in the Early Detection of Recurrence in Surgically Treated Prostate Cancer Patients With Very Low PSA Level <0.5 ng/mL
Marcelo Mamede et al.
CLINICAL NUCLEAR MEDICINE (2013)
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
A. Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
11C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy
Francesco Ceci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Management of Biochemical Recurrence After Primary Treatment of Prostate Cancer: A Systematic Review of the Literature
Sanoj Punnen et al.
EUROPEAN UROLOGY (2013)
Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer
Jan D. Soyka et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
A Critical Analysis of the Long-Term Impact of Radical Prostatectomy on Cancer Control and Function Outcomes
Stephen A. Boorjian et al.
EUROPEAN UROLOGY (2012)
Is there a role for C-11-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase < 1.5 ng/ml?
Paolo Castellucci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy
Toni K. Choueiri et al.
JOURNAL OF UROLOGY (2008)
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
Andrew J. Stephenson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1-T3 prostate carcinoma in the prostate-specific antigen era - What should we expect?
D Khuntia et al.
CANCER (2004)
Time trends in biochemical recurrence after radical prostatectomy: Results of the search database
SJ Freedland et al.
UROLOGY (2003)
分享论文
